Form 4: Surrozen Director Acquires Stock Options

Anna Berkenblit, a Director at Surrozen, Inc., acquired 5,550 stock options with an exercise price of $30.14.

Summary

• Anna Berkenblit, a Director at Surrozen, Inc., acquired 5,550 stock options on May 13, 2026.
• The options have an exercise price of $30.14 per share.
• These options are exercisable starting May 13, 2027, and expire on May 12, 2036.
• The acquisition is part of a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard director stock option grant under a pre-arranged plan, with no immediate financial impact or significant change in company strategy.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The acquisition was made under a Rule 10b5-1(c) plan, suggesting a pre-determined and structured approach to trading.

Risks

• The value of the acquired options is directly tied to the future stock price of Surrozen, Inc., which is subject to market volatility and company performance.
• The vesting schedule means the options are not immediately available for exercise, requiring continued service as a director.

Future Outlook

The future outlook for the stock options is dependent on Surrozen, Inc.'s performance and market conditions, as the options are exercisable from May 13, 2027, to May 12, 2036.

Industry Context

StockSavvy.ai notes that director acquisitions of stock options are common in the biotechnology and pharmaceutical sectors, often used as a long-term incentive tied to company growth and value creation.

Stakeholder Impact

• Shareholders: The acquisition itself does not immediately dilute share count, but future exercise of options could lead to dilution. It may be viewed positively as a sign of director commitment.
• Employees: No direct impact, but successful company performance that increases stock value benefits all stakeholders.
• Management: Reinforces the alignment of director interests with shareholder interests.

Next Steps

• Anna Berkenblit will continue to hold the stock options, subject to vesting conditions.
• The options can be exercised between May 13, 2027, and May 12, 2036, if the company's stock price exceeds the $30.14 exercise price.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, Director, Surrozen Inc., SRZN, Beneficial Ownership, Rule 10b5-1(c)